BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28221895)

  • 1. Use of Evidence-Based Prostate Cancer Imaging in a Nongovernmental Integrated Health Care System.
    Salloum RG; O'Keeffe-Rosetti M; Ritzwoller DP; Hornbrook MC; Lafata JE; Nielsen ME
    J Oncol Pract; 2017 May; 13(5):e441-e450. PubMed ID: 28221895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care?
    Hahn EE; Tang T; Lee JS; Munoz-Plaza CE; Shen E; Rowley B; Maeda JL; Mosen DM; Ruckdeschel JC; Gould MK
    Cancer; 2016 Mar; 122(6):908-16. PubMed ID: 26650715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinician-centred programme for behaviour change in the optimal use of staging investigations for newly diagnosed prostate cancer.
    Rutledge AB; McLeod N; Mehan N; Regan TW; Ainsworth P; Chong P; Doyle T; White M; Sanson-Fisher RW; Martin JM
    BJU Int; 2018 May; 121 Suppl 3():22-27. PubMed ID: 29359883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population.
    Makarov DV; Desai RA; Yu JB; Sharma R; Abraham N; Albertsen PC; Penson DF; Gross CP
    J Urol; 2012 Jan; 187(1):97-102. PubMed ID: 22088337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUSIC: patterns of care in the radiographic staging of men with newly diagnosed low risk prostate cancer.
    Ross I; Womble P; Ye J; Linsell S; Montie JE; Miller DC; Cher ML
    J Urol; 2015 Apr; 193(4):1159-62. PubMed ID: 25444985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States.
    Prasad SM; Gu X; Lipsitz SR; Nguyen PL; Hu JC
    Cancer; 2012 Mar; 118(5):1260-7. PubMed ID: 21823112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health Care Integration and Quality among Men with Prostate Cancer.
    Herrel LA; Kaufman SR; Yan P; Miller DC; Schroeck FR; Skolarus TA; Shahinian VB; Hollenbeck BK
    J Urol; 2017 Jan; 197(1):55-60. PubMed ID: 27423758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Statewide Intervention Improves Appropriate Imaging in Localized Prostate Cancer.
    Hurley P; Dhir A; Gao Y; Drabik B; Lim K; Curry J; Womble PR; Linsell SM; Brachulis A; Sexton DW; Ghani KR; Denton BT; Miller DC; Montie JE;
    J Urol; 2017 May; 197(5):1222-1228. PubMed ID: 27889418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act.
    Mahal BA; Aizer AA; Ziehr DR; Hyatt AS; Lago-Hernandez C; Chen YW; Choueiri TK; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Trinh QD; Nguyen PL
    Prostate Cancer Prostatic Dis; 2014 Sep; 17(3):273-9. PubMed ID: 24980272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second opinions from urologists for prostate cancer: Who gets them, why, and their link to treatment.
    Radhakrishnan A; Grande D; Mitra N; Bekelman J; Stillson C; Pollack CE
    Cancer; 2017 May; 123(6):1027-1034. PubMed ID: 28263389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor.
    Cooperberg MR; Lubeck DP; Grossfeld GD; Mehta SS; Carroll PR
    J Urol; 2002 Aug; 168(2):491-5. PubMed ID: 12131295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring integrated care.
    Strandberg-Larsen M
    Dan Med Bull; 2011 Feb; 58(2):B4245. PubMed ID: 21299927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate brachytherapy: a descriptive analysis from CaPSURE.
    Lee WR; Sharkey J; Cowan JE; DuChane J; Carroll PR;
    Brachytherapy; 2007; 6(2):123-8. PubMed ID: 17434105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
    Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
    BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort.
    Palvolgyi R; Daskivich TJ; Chamie K; Kwan L; Litwin MS
    Urology; 2011 Jun; 77(6):1330-6. PubMed ID: 21492911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies.
    Radtke JP; Wiesenfarth M; Kesch C; Freitag MT; Alt CD; Celik K; Distler F; Roth W; Wieczorek K; Stock C; Duensing S; Roethke MC; Teber D; Schlemmer HP; Hohenfellner M; Bonekamp D; Hadaschik BA
    Eur Urol; 2017 Dec; 72(6):888-896. PubMed ID: 28400169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated trends in imaging use in men diagnosed with prostate cancer.
    Porten SP; Smith A; Odisho AY; Litwin MS; Saigal CS; Carroll PR; Cooperberg MR;
    Prostate Cancer Prostatic Dis; 2014 Sep; 17(3):246-51. PubMed ID: 24819235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.
    Chamie K; DeVere White RW; Lee D; Ok JH; Ellison LM
    Cancer; 2008 Nov; 113(9):2464-70. PubMed ID: 18666213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of imaging for staging of early-stage breast cancer in two integrated health care systems: adherence with a choosing wisely recommendation.
    Hahn EE; Tang T; Lee JS; Munoz-Plaza C; Adesina JO; Shen E; Rowley B; Maeda JL; Mosen DM; Ruckdeschel JC; Gould MK
    J Oncol Pract; 2015 May; 11(3):e320-8. PubMed ID: 25901056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of the overuse of imaging in low-risk prostate cancer: A systematic review.
    Oakes AH; Sharma R; Jackson M; Segal JB
    Urol Oncol; 2017 Nov; 35(11):647-658. PubMed ID: 28943200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.